全球医院感染控制市场 - 行业趋势及 2029 年预测

市场分析和规模          

过去十年，随着技术的进步和创新医疗设备的采用，医疗保健基础设施发生了巨大变化。随着过去十年各种传染病和慢性病的发病率不断上升，对消毒和灭菌设备的需求变得比以往任何时候都更加迫切。

Data Bridge Market Research 分析称，2021 年医院感染控制市场价值为 291 亿美元，预计到 2029 年将达到 341 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 9.90%。

Market Definition

Hospital Acquired Infection Control Market Dynamics              

Drivers

Major factors that are expected to boost the growth of the hospital acquired infection control market in the forecast period are as follows:

• Rise in the prevalence of hospital-acquired infections (HAIs)

As a result of a lack of preventive measures, there is an increase in the number of hospital-acquired infections. In hospitals, infections are frequently caused by contaminated medical equipment and devices will further accelerate the demand for the hospital acquired infection control market.

• Growing number of surgical procedures

Over the years, there has been a significant increase in the number of surgical procedures performed worldwide as a result of lifestyle diseases, the growing geriatric population, and the increasing incidence of spinal injuries are the major drivers that will enhance the growth of market.

• Growing of elderly population

Chronic diseases such as cardiovascular disease, cancer, diabetes, and other autoimmune diseases are becoming more common as the world's population ages which is further anticipated to propel the growth of the hospital acquired infection control market.

Opportunities

In addition, the growing adoption of single-use medical nonwovens and devices are further estimated to provide potential opportunities for the growth of the hospital acquired infection control market in the coming years.

Restraints/Challenges

On the other hand, the increased cost of endoscopy reprocessing and inadequate reimbursement in the advancing countries is further projected to impede the growth of the hospital acquired infection control market in the targeted period. However, the difficulties regarding the hospital-acquired infection control procedures might further challenge the growth of the hospital acquired infection control market in the near future.

This hospital acquired infection control market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hospital acquired infection control market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Hospital Acquired Infection Control Market

The pandemic of COVID-19 has had a huge impact on the hospital acquired infection control market. The pandemic has wreaked havoc on healthcare systems around the world, with hospitals becoming overburdened as the number of patients continues to rise. Temporary hospitals were also established to handle the increasing number of cases. As a result of the increasing cases of hospital acquired infection in hospital settings, the spread of COVID-19 has resulted in an increase in demand for HAI services. However, in the aftermath of the pandemic, the severe consequences of COVID-19, such as hospitalisation, may help the hospital-acquired infection control industry gain traction in the coming years.

Recent Development

• In September 2021, Sodexo has expanded its partnership with Ecolab in the United States for the control of hospital-acquired infections through the Protecta Plus programme. This programme was created to reduce infection risk in hospitals and healthcare facilities by utilising Ecolab's Bioquell hydrogen peroxide vapour technology.

Global Hospital Acquired Infection Control Market Scope and Market Size

The hospital acquired infection control market is segmented on the basis of product, application, technology, disease and end users. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Sterilizers
• Disinfectors
• Endoscope Reprocessors
• Microbial Testing Instruments
• Reagents
• Consumables
• Disinfectants
• Infection Prevention and Surveillance Software
• Others

On the basis of product, the hospital acquired infection control market is segmented into sterilizers, disinfectors, endoscope reprocessors, microbial testing instruments, reagents, consumables, disinfectants, infection prevention and surveillance software and others. Sterilizers have been further sub segmented into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment and others. Heat sterilization equipment is further sub segmented into moist heat sterilization equipment and dry heat sterilization equipment. Disinfectors have been further sub segmented into washer disinfector and flusher disinfector. Endoscope reprocessors have been further sub segmented into single basin endoscopic reprocessors and dual basin endoscopic reprocessors. Microbial testing instruments have been further sub segmented into automated microbial identification systems, polymerase chain reaction (PCR) instruments, mass spectrometers, microarrays, polystainers, flow cytometers and others. Disinfectants have been further sub segmented into type and formulation. Type has been further sub segmented into hand disinfectants, skin disinfectants, instrument disinfectants and surface disinfectants/disinfectant robots. Formulation has been further sub segmented into disinfectant wipes, disinfectant liquids and disinfectant sprays.

Application

• Disease Testing
• Drug-Resistance Testing

On the basis application, the hospital acquired infection control market is segmented into disease testing and drug-resistance testing.

Technology

• Phenotypic Methods
• Genotypic Methods

On the basis of technology, the hospital acquired infection control market is segmented into phenotypic methods and genotypic methods. Phenotypic methods has been further sub segmented into phage-based assays, colorimetric methods and nitrate reductase assay. Genotypic methods has been further sub segmented into DNA sequencing, solid-phase hybridization techniques, polymerase chain reaction (PCR) techniques and microarrays.

Disease

• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infection
• Others

On the basis of disease, the hospital acquired infection control market is segmented into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI) and others.

End Users

• Hospitals
• ICUs
• Ambulatory Surgical
• Diagnostic Centers
• Nursing Homes
• Maternity Centers
• Others

On the basis of end users, the hospital acquired infection control market is segmented into hospitals, intensive care units (ICUs), ambulatory surgical, diagnostic centers, nursing homes, maternity centers and others.

Hospital Acquired Infection Control Market Regional Analysis/Insights

The hospital acquired infection control market is analysed and market size insights and trends are provided by country, product, application, technology, disease and end users as referenced above.

The countries covered in the hospital acquired infection control market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the hospital acquired infection control market due to the rise in the major healthcare facilities and authorities on the prevention and spread of any infections originating from different healthcare facilities. Furthermore, the increase in the awareness of hospital acquired infection will further boost the growth of the hospital acquired infection control market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth in the hospital acquired infection control market due to the rise in the incidence of hospital acquired infections and advancing healthcare infrastructure in low and middle-income countries. Moreover, the newborns in the advancing countries are at a higher risk of contracting healthcare-associated infections than in developed countries which is further anticipated to propel the growth of the hospital acquired infection control market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The hospital acquired infection control market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hospital acquired infection control market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hospital acquired infection control market. The data is available for historic period 2010-2020.

Competitive Landscape and Hospital Acquired Infection Control Market Share Analysis

医院获得性感染控制市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对医院获得性感染控制市场的关注有关。

 医院感染控制市场的一些主要参与者包括：

• 奥林巴斯株式会社（日本）
• Cantel Medical（美国）
• Getinge AB（瑞典）
• STERIS plc（美国）
• Belimed（瑞士）
• STEELCO SpA（意大利）
• ASP（美国）
• BD（美国）
• Crosstex International, Inc.（美国）
• Diversey 公司 (美国)
• MMM 集团（美国）
• 3M（美国）
• 生物梅里埃公司（法国）
• Sterigenics US, LLC（美国）
• 造父变星（美国）
• Dentsply Sirona（美国）
• 迈瑞生物医疗电子股份有限公司 (中国)
• Randox Laboratories Ltd.（英国）
• Ortho Clinical Diagnostics（美国）
• Nova Biomedical（英国）
• Sysmex 公司 (日本)

SKU-24749